Clinical Trial Update: Docetaxel With or Without Bintrafusp Alfa for the Treatment of Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 randomized study comparing docetaxel alone versus docetaxel with bintrafusp alfa in advanced non-small cell lung cancer was terminated, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bintrafusp alfa (bintrafusp alfa)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Mayo Clinic | Conditions: Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 | Phase 2 | Status: TERMINATED | Results posted: 2025-11-17